Previous Article | Next Article 
Molecular and Cellular Biology, July 2000, p. 4699-4707, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Peroxisome Proliferator-Activated Receptor
-Dependent
Repression of the Inducible Nitric Oxide Synthase Gene
Mei
Li,
Gabriel
Pascual, and
Christopher K.
Glass*
Department of Cellular and Molecular Medicine
and Department of Medicine, Division of Endocrinology and
Metabolism, University of California, San Diego, La Jolla, California
92093-06511
Received 28 September 1999/Returned for modification 17 November
1999/Accepted 10 April 2000
The peroxisome proliferator-activated receptor
(PPAR
) is a
member of the nuclear receptor superfamily that activates target gene
transcription in a ligand-dependent manner. In addition, liganded
PPAR
can inhibit transcription of genes induced by gamma interferon (IFN-
) and/or lipopolysaccharides (LPSs), including the inducible nitric oxide synthase (iNOS) gene. Inhibition of the iNOS
promoter is achieved partially through antagonizing the activities of NF-
B, AP-1, and STAT1, which are known to mediate effects of LPS and IFN-
. Previous studies have suggested that transrepression of these factors by nuclear receptors involves competition for limiting amounts of the general coactivators
CREB-binding protein (CBP) and p300. CBP and p300 are thought to be
recruited to nuclear receptors through bridging factors that include
SRC-1, although CBP also interacts directly with PPAR
through its
amino terminus. These observations have raised questions
concerning the involvement of SRC-1-like factors in CBP
recruitment and transrepression. We here provide evidence that
PPAR
's ability to repress iNOS transcription requires the
ligand-dependent charge clamp that mediates interactions with CBP
and SRC-1. Single amino acid mutations in PPAR
that abolished
ligand-dependent interactions with SRC-1 and CBP not only
resulted in complete loss of transactivation activity but also
abolished transrepression. Conversely, a CBP deletion mutant containing
the SRC-1 interaction domain but lacking the N-terminal
PPAR
interaction domain was inactive as a PPAR
coactivator and
failed to rescue transrepression. Together, these findings
are consistent with a model in which transrepression by PPAR
is
achieved by targeting CBP through direct interaction with its
N-terminal domain and via SRC-1-like bridge factors.
*
Corresponding author. Mailing address: Department of
Cellular and Molecular Medicine and Department of Medicine, Division of
Endocrinology and Metabolism, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0651. Phone: (858) 534-6011. Fax: (858)
822-2127. E-mail: cglass{at}ucsd.edu.
Molecular and Cellular Biology, July 2000, p. 4699-4707, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kumar, A. P., Quake, A. L., Chang, M. K. X., Zhou, T., Lim, K. S. Y., Singh, R., Hewitt, R. E., Salto-Tellez, M., Pervaiz, S., Clement, M.-V.
(2009). Repression of NHE1 Expression by PPAR{gamma} Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo. Cancer Res.
69: 8636-8644
[Abstract]
[Full Text]
-
Ghosh, A. K., Bhattacharyya, S., Wei, J., Kim, S., Barak, Y., Mori, Y., Varga, J.
(2009). Peroxisome proliferator-activated receptor-{gamma} abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator. FASEB J.
23: 2968-2977
[Abstract]
[Full Text]
-
Remels, A. H. V., Langen, R. C. J., Gosker, H. R., Russell, A. P., Spaapen, F., Voncken, J. W., Schrauwen, P., Schols, A. M. W. J.
(2009). PPAR{gamma} inhibits NF-{kappa}B-dependent transcriptional activation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab.
297: E174-E183
[Abstract]
[Full Text]
-
Yuhas, Y., Berent, E., Cohen, R., Ashkenazi, S.
(2009). Roles of NF-{kappa}B Activation and Peroxisome Proliferator-Activated Receptor Gamma Inhibition in the Effect of Rifampin on Inducible Nitric Oxide Synthase Transcription in Human Lung Epithelial Cells. Antimicrob. Agents Chemother.
53: 1539-1545
[Abstract]
[Full Text]
-
Perez-Cano, F. J., Ramirez-Santana, C., Molero-Luis, M., Castell, M., Rivero, M., Castellote, C., Franch, A.
(2009). Mucosal IgA increase in rats by continuous CLA feeding during suckling and early infancy. J. Lipid Res.
50: 467-476
[Abstract]
[Full Text]
-
Jennewein, C., Kuhn, A.-M., Schmidt, M. V., Meilladec-Jullig, V., von Knethen, A., Gonzalez, F. J., Brune, B.
(2008). Sumoylation of Peroxisome Proliferator-Activated Receptor {gamma} by Apoptotic Cells Prevents Lipopolysaccharide-Induced NCoR Removal from {kappa}B Binding Sites Mediating Transrepression of Proinflammatory Cytokines. J. Immunol.
181: 5646-5652
[Abstract]
[Full Text]
-
Anderson, N., Borlak, J.
(2008). Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis. Pharmacol. Rev.
60: 311-357
[Abstract]
[Full Text]
-
Bonfield, T. L., Thomassen, M. J., Farver, C. F., Abraham, S., Koloze, M. T., Zhang, X., Mosser, D. M., Culver, D. A.
(2008). Peroxisome Proliferator-Activated Receptor-{gamma} Regulates the Expression of Alveolar Macrophage Macrophage Colony-Stimulating Factor. J. Immunol.
181: 235-242
[Abstract]
[Full Text]
-
Remels, A. H., Gosker, H. R., Schrauwen, P., Langen, R. C., Schols, A. M.
(2008). Peroxisome proliferator-activated receptors: a therapeutic target in COPD?. Eur Respir J
31: 502-508
[Abstract]
[Full Text]
-
Plummer, S., Sharpe, R. M., Hallmark, N., Mahood, I. K., Elcombe, C.
(2007). Time-Dependent and Compartment-Specific Effects of In Utero Exposure to Di(n-butyl) Phthalate on Gene/Protein Expression in the Fetal Rat Testis as Revealed by Transcription Profiling and Laser Capture Microdissection. Toxicol Sci
97: 520-532
[Abstract]
[Full Text]
-
Lee, K. S., Park, S. J., Kim, S. R., Min, K. H., Jin, S. M., Lee, H. K., Lee, Y. C.
(2006). Modulation of Airway Remodeling and Airway Inflammation by Peroxisome Proliferator-Activated Receptor {gamma} in a Murine Model of Toluene Diisocyanate-Induced Asthma. J. Immunol.
177: 5248-5257
[Abstract]
[Full Text]
-
Kasper, L. H., Fukuyama, T., Biesen, M. A., Boussouar, F., Tong, C., de Pauw, A., Murray, P. J., van Deursen, J. M. A., Brindle, P. K.
(2006). Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development. Mol. Cell. Biol.
26: 789-809
[Abstract]
[Full Text]
-
Lu, D., Cottam, H. B., Corr, M., Carson, D. A.
(2005). Repression of {beta}-catenin function in malignant cells by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA
102: 18567-18571
[Abstract]
[Full Text]
-
Ji, J. D., Kim, H. J., Rho, Y. H., Choi, S. J., Lee, Y. H., Cheon, H. J., Sohn, J., Song, G. G.
(2005). Inhibition of IL-10-induced STAT3 activation by 15-deoxy-{Delta}12,14-prostaglandin J2. Rheumatology (Oxford)
44: 983-988
[Abstract]
[Full Text]
-
Berry, E. B. E., Keelan, J. A., Helliwell, R. J. A., Gilmour, R. S., Mitchell, M. D.
(2005). Nanomolar and Micromolar Effects of 15-Deoxy-{Delta}12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors {gamma} and {delta} and Nuclear Factor {kappa}B. Mol. Pharmacol.
68: 169-178
[Abstract]
[Full Text]
-
Ialenti, A., Grassia, G., Di Meglio, P., Maffia, P., Di Rosa, M., Ianaro, A.
(2005). Mechanism of the Anti-Inflammatory Effect of Thiazolidinediones: Relationship with the Glucocorticoid Pathway. Mol. Pharmacol.
67: 1620-1628
[Abstract]
[Full Text]
-
Carvalho-Filho, M. A., Ueno, M., Hirabara, S. M., Seabra, A. B., Carvalheira, J. B.C., de Oliveira, M. G., Velloso, L. A., Curi, R., Saad, M. J.A.
(2005). S-Nitrosation of the Insulin Receptor, Insulin Receptor Substrate 1, and Protein Kinase B/Akt: A Novel Mechanism of Insulin Resistance. Diabetes
54: 959-967
[Abstract]
[Full Text]
-
Migita, H., Morser, J.
(2005). 15-Deoxy-{Delta}12,14-Prostaglandin J2 (15d-PGJ2) Signals Through Retinoic Acid Receptor-Related Orphan Receptor-{alpha} but Not Peroxisome Proliferator-Activated Receptor-{gamma} in Human Vascular Endothelial Cells: The Effect of 15d-PGJ2 on Tumor Necrosis Factor-{alpha}-Induced Gene Expression. Arterioscler. Thromb. Vasc. Bio.
25: 710-716
[Abstract]
[Full Text]
-
Makowski, L., Brittingham, K. C., Reynolds, J. M., Suttles, J., Hotamisligil, G. S.
(2005). The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity: MACROPHAGE EXPRESSION OF aP2 IMPACTS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR {gamma} AND I{kappa}B KINASE ACTIVITIES. J. Biol. Chem.
280: 12888-12895
[Abstract]
[Full Text]
-
Julan, L., Guan, H., van Beek, J. P., Yang, K.
(2005). Peroxisome Proliferator-Activated Receptor {delta} Suppresses 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Human Placental Trophoblast Cells. Endocrinology
146: 1482-1490
[Abstract]
[Full Text]
-
Abdelrahman, M., Sivarajah, A., Thiemermann, C.
(2005). Beneficial effects of PPAR-{gamma} ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res
65: 772-781
[Abstract]
[Full Text]
-
Crosby, M. B., Svenson, J. L., Zhang, J., Nicol, C. J., Gonzalez, F. J., Gilkeson, G. S.
(2005). Peroxisome Proliferation-Activated Receptor (PPAR){gamma} Is Not Necessary for Synthetic PPAR{gamma} Agonist Inhibition of Inducible Nitric-Oxide Synthase and Nitric Oxide. J. Pharmacol. Exp. Ther.
312: 69-76
[Abstract]
[Full Text]
-
Chen, F.
(2004). Endogenous Inhibitors of Nuclear Factor-{kappa}B, An Opportunity for Cancer Control. Cancer Res.
64: 8135-8138
[Abstract]
[Full Text]
-
Zhang, X., Rodriguez-Galan, M. C., Subleski, J. J., Ortaldo, J. R., Hodge, D. L., Wang, J.-M., Shimozato, O., Reynolds, D. A., Young, H. A.
(2004). Peroxisome proliferator-activated receptor-{gamma} and its ligands attenuate biologic functions of human natural killer cells. Blood
104: 3276-3284
[Abstract]
[Full Text]
-
Birrell, M.A., Patel, H.J., McCluskie, K., Wong, S., Leonard, T., Yacoub, M.H., Belvisi, M.G.
(2004). PPAR-{gamma} agonists as therapy for diseases involving airway neutrophilia. Eur Respir J
24: 18-23
[Abstract]
[Full Text]
-
Cunard, R., Eto, Y., Muljadi, J. T., Glass, C. K., Kelly, C. J., Ricote, M.
(2004). Repression of IFN-{gamma} Expression by Peroxisome Proliferator-Activated Receptor {gamma}. J. Immunol.
172: 7530-7536
[Abstract]
[Full Text]
-
Cheron, A., Peltier, J., Perez, J., Bellocq, A., Fouqueray, B., Baud, L.
(2004). 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Glucocorticoid Binding and Signaling in Macrophages through a Peroxisome Proliferator-Activated Receptor {gamma}-Independent Process. J. Immunol.
172: 7677-7683
[Abstract]
[Full Text]
-
Pilon, G., Dallaire, P., Marette, A.
(2004). Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase: A NEW MECHANISM OF ACTION OF INSULIN-SENSITIZING DRUGS. J. Biol. Chem.
279: 20767-20774
[Abstract]
[Full Text]
-
Kumar, A. P., Piedrafita, F. J., Reynolds, W. F.
(2004). Peroxisome Proliferator-activated Receptor {gamma} Ligands Regulate Myeloperoxidase Expression in Macrophages by an Estrogen-dependent Mechanism Involving the -463GA Promoter Polymorphism. J. Biol. Chem.
279: 8300-8315
[Abstract]
[Full Text]
-
Meissner, M., Stein, M., Urbich, C., Reisinger, K., Suske, G., Staels, B., Kaufmann, R., Gille, J.
(2004). PPAR{alpha} Activators Inhibit Vascular Endothelial Growth Factor Receptor-2 Expression by Repressing Sp1-Dependent DNA Binding and Transactivation. Circ. Res.
94: 324-332
[Abstract]
[Full Text]
-
Asada, K., Sasaki, S., Suda, T., Chida, K., Nakamura, H.
(2004). Antiinflammatory Roles of Peroxisome Proliferator-activated Receptor {gamma} in Human Alveolar Macrophages. Am. J. Respir. Crit. Care Med.
169: 195-200
[Abstract]
[Full Text]
-
Wu, J., Li, Y., Dietz, J., Lala, D. S.
(2004). Repression of p65 Transcriptional Activation by the Glucocorticoid Receptor in the Absence of Receptor-Coactivator Interactions. Mol. Endocrinol.
18: 53-62
[Abstract]
[Full Text]
-
Culver, D. A., Barna, B. P., Raychaudhuri, B., Bonfield, T. L., Abraham, S., Malur, A., Farver, C. F., Kavuru, M. S., Thomassen, M. J.
(2004). Peroxisome Proliferator-Activated Receptor {gamma} Activity Is Deficient in Alveolar Macrophages in Pulmonary Sarcoidosis. Am. J. Respir. Cell Mol. Bio.
30: 1-5
[Abstract]
[Full Text]
-
Perez-Sala, D., Cernuda-Morollon, E., Canada, F. J.
(2003). Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-{Delta}12,14-prostaglandin J2. J. Biol. Chem.
278: 51251-51260
[Abstract]
[Full Text]
-
Zingarelli, B., Sheehan, M., Hake, P. W., O'Connor, M., Denenberg, A., Cook, J. A.
(2003). Peroxisome Proliferator Activator Receptor-{gamma} Ligands, 15-Deoxy-{Delta}12,14-Prostaglandin J2 and Ciglitazone, Reduce Systemic Inflammation in Polymicrobial Sepsis by Modulation of Signal Transduction Pathways. J. Immunol.
171: 6827-6837
[Abstract]
[Full Text]
-
Tao, L., Liu, H.-R., Gao, E., Teng, Z.-P., Lopez, B. L., Christopher, T. A., Ma, X.-L., Batinic-Haberle, I., Willette, R. N., Ohlstein, E. H., Yue, T.-L.
(2003). Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist in Hypercholesterolemia. Circulation
108: 2805-2811
[Abstract]
[Full Text]
-
Yang, L., Yan, D., Yan, C., Du, H.
(2003). Peroxisome Proliferator-activated Receptor {gamma} and Ligands Inhibit Surfactant Protein B Gene Expression in the Lung. J. Biol. Chem.
278: 36841-36847
[Abstract]
[Full Text]
-
Chen, C.-W., Chang, Y.-H., Tsi, C.-J., Lin, W.-W.
(2003). Inhibition of IFN-{gamma}-Mediated Inducible Nitric Oxide Synthase Induction by the Peroxisome Proliferator-Activated Receptor {gamma} Agonist, 15-Deoxy-{Delta}12,14-Prostaglandin J2, Involves Inhibition of the Upstream Janus Kinase/STAT1 Signaling Pathway. J. Immunol.
171: 979-988
[Abstract]
[Full Text]
-
Jones, D. C., Ding, X., Zhang, T. Y., Daynes, R. A.
(2003). Peroxisome Proliferator-Activated Receptor {alpha} Negatively Regulates T-bet Transcription Through Suppression of p38 Mitogen-Activated Protein Kinase Activation. J. Immunol.
171: 196-203
[Abstract]
[Full Text]
-
Cao, W., Bao, C., Lowenstein, C. J.
(2003). Inducible nitric oxide synthase expression inhibition by adenovirus E1A. Proc. Natl. Acad. Sci. USA
100: 7773-7778
[Abstract]
[Full Text]
-
Bruemmer, D., Yin, F., Liu, J., Berger, J. P., Kiyono, T., Chen, J., Fleck, E., Van Herle, A. J., Forman, B. M., Law, R. E.
(2003). Peroxisome Proliferator-Activated Receptor {gamma} Inhibits Expression of Minichromosome Maintenance Proteins in Vascular Smooth Muscle Cells. Mol. Endocrinol.
17: 1005-1018
[Abstract]
[Full Text]
-
Welch, J. S., Ricote, M., Akiyama, T. E., Gonzalez, F. J., Glass, C. K.
(2003). PPAR{gamma} and PPAR{delta} negatively regulate specific subsets of lipopolysaccharide and IFN-{gamma} target genes in macrophages. Proc. Natl. Acad. Sci. USA
100: 6712-6717
[Abstract]
[Full Text]
-
Lee, T.-S., Tsai, H.-L., Chau, L.-Y.
(2003). Induction of Heme Oxygenase-1 Expression in Murine Macrophages Is Essential for the Anti-inflammatory Effect of Low Dose 15-Deoxy-{Delta}12,14-prostaglandin J2. J. Biol. Chem.
278: 19325-19330
[Abstract]
[Full Text]
-
Tautenhahn, A., Brune, B., von Knethen, A.
(2003). Activation-induced PPAR{gamma} expression sensitizes primary human T cells toward apoptosis. J. Leukoc. Biol.
73: 665-672
[Abstract]
[Full Text]
-
Ceriello, A.
(2003). New Insights on Oxidative Stress and Diabetic Complications May Lead to a "Causal" Antioxidant Therapy. Diabetes Care
26: 1589-1596
[Abstract]
[Full Text]
-
Kuncewicz, T., Sheta, E. A., Goldknopf, I. L., Kone, B. C.
(2003). Proteomic Analysis of S-Nitrosylated Proteins in Mesangial Cells. Mol. Cell. Proteomics
2: 156-163
[Abstract]
[Full Text]
-
Maira, M., Martens, C., Batsche, E., Gauthier, Y., Drouin, J.
(2003). Dimer-Specific Potentiation of NGFI-B (Nur77) Transcriptional Activity by the Protein Kinase A Pathway and AF-1-Dependent Coactivator Recruitment. Mol. Cell. Biol.
23: 763-776
[Abstract]
[Full Text]
-
Koeffler, H. P.
(2003). Peroxisome Proliferator-activated Receptor {gamma} and Cancers. Clin. Cancer Res.
9: 1-9
[Abstract]
[Full Text]
-
Girnun, G. D., Domann, F. E., Moore, S. A., Robbins, M. E. C.
(2002). Identification of a Functional Peroxisome Proliferator-Activated Receptor Response Element in the Rat Catalase Promoter. Mol. Endocrinol.
16: 2793-2801
[Abstract]
[Full Text]
-
Kintscher, U., Lyon, C., Wakino, S., Bruemmer, D., Feng, X., Goetze, S., Graf, K., Moustakas, A., Staels, B., Fleck, E., Hsueh, W. A., Law, R. E.
(2002). PPAR{alpha} Inhibits TGF-{beta}-Induced {beta}5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4. Circ. Res.
91
: e35-e44
[Abstract]
[Full Text]
-
Kluft, C., Kleemann, R., de Maat, M.P.M.
(2002). How best to counteract the enemies? By controlling inflammation in the coronary circulation. Eur Heart J Suppl
4: G53-G65
[Abstract]
-
Cernuda-Morollon, E., Rodriguez-Pascual, F., Klatt, P., Lamas, S., Perez-Sala, D.
(2002). PPAR Agonists Amplify iNOS Expression While Inhibiting NF-{kappa}B: Implications for Mesangial Cell Activation by Cytokines. J. Am. Soc. Nephrol.
13: 2223-2231
[Abstract]
[Full Text]
-
von Knethen, A., Brune, B.
(2002). Activation of Peroxisome Proliferator-Activated Receptor {gamma} by Nitric Oxide in Monocytes/Macrophages Down-Regulates p47phox and Attenuates the Respiratory Burst. J. Immunol.
169: 2619-2626
[Abstract]
[Full Text]
-
Hartman, H. B., Hu, X., Tyler, K. X., Dalal, C. K., Lazar, M. A.
(2002). Mechanisms Regulating Adipocyte Expression of Resistin. J. Biol. Chem.
277: 19754-19761
[Abstract]
[Full Text]
-
Li, Y., Lazar, M. A.
(2002). Differential Gene Regulation by PPAR{gamma} Agonist and Constitutively Active PPAR{gamma}2. Mol. Endocrinol.
16: 1040-1048
[Abstract]
[Full Text]
-
Sugawara, A., Uruno, A., Kudo, M., Ikeda, Y., Sato, K., Taniyama, Y., Ito, S., Takeuchi, K.
(2002). Transcription Suppression of Thromboxane Receptor Gene by Peroxisome Proliferator-activated Receptor-gamma via an Interaction with Sp1 in Vascular Smooth Muscle Cells. J. Biol. Chem.
277: 9676-9683
[Abstract]
[Full Text]
-
Kone, B. C
(2001). Molecular biology of natriuretic peptides and nitric oxide synthases. Cardiovasc Res
51: 429-441
[Abstract]
[Full Text]
-
Eeckhoute, J., Formstecher, P., Laine, B.
(2001). Maturity-Onset Diabetes of the Young Type 1 (MODY1)-Associated Mutations R154X and E276Q in Hepatocyte Nuclear Factor 4{{alpha}} (HNF4{{alpha}}) Gene Impair Recruitment of p300, a Key Transcriptional Coactivator. Mol. Endocrinol.
15: 1200-1210
[Abstract]
[Full Text]
-
Zhang, X., Wang, J. M., Gong, W. H., Mukaida, N., Young, H. A.
(2001). Differential Regulation of Chemokine Gene Expression by 15-Deoxy-{{Delta}}12,1412,14 Prostaglandin J2. J. Immunol.
166: 7104-7111
[Abstract]
[Full Text]
-
Wang, A. C. C., Dai, X., Luu, B., Conrad, D. J.
(2001). Peroxisome Proliferator-Activated Receptor-gamma Regulates Airway Epithelial Cell Activation. Am. J. Respir. Cell Mol. Bio.
24: 688-693
[Abstract]
[Full Text]
-
Wang, C., Fu, M., D'Amico, M., Albanese, C., Zhou, J.-N., Brownlee, M., Lisanti, M. P., Chatterjee, V. K. K., Lazar, M. A., Pestell, R. G.
(2001). Inhibition of Cellular Proliferation through I{kappa}B Kinase-Independent and Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Repression of Cyclin D1. Mol. Cell. Biol.
21: 3057-3070
[Abstract]
[Full Text]
-
Subbaramaiah, K., Lin, D. T., Hart, J. C., Dannenberg, A. J.
(2001). Peroxisome Proliferator-activated Receptor gamma Ligands Suppress the Transcriptional Activation of Cyclooxygenase-2. EVIDENCE FOR INVOLVEMENT OF ACTIVATOR PROTEIN-1 AND CREB-BINDING PROTEIN/p300. J. Biol. Chem.
276: 12440-12448
[Abstract]
[Full Text]
-
Warnmark, A., Almlof, T., Leers, J., Gustafsson, J.-A., Treuter, E.
(2001). Differential Recruitment of the Mammalian Mediator Subunit TRAP220 by Estrogen Receptors ERalpha and ERbeta. J. Biol. Chem.
276: 23397-23404
[Abstract]
[Full Text]
-
Castrillo, A., Mojena, M., Hortelano, S., Bosca, L.
(2001). Peroxisome Proliferator-activated Receptor-gamma -independent Inhibition of Macrophage Activation by the Non-thiazolidinedione Agonist L-796,449. COMPARISON WITH THE EFFECTS OF 15-DEOXY-Delta 12,14-PROSTAGLANDIN J2. J. Biol. Chem.
276: 34082-34088
[Abstract]
[Full Text]
-
Hunter, J. G., van Delft, M. F., Rachubinski, R. A., Capone, J. P.
(2001). Peroxisome Proliferator-activated Receptor gamma Ligands Differentially Modulate Muscle Cell Differentiation and MyoD Gene Expression via Peroxisome Proliferator-activated Receptor gamma -dependent and -independent Pathways. J. Biol. Chem.
276: 38297-38306
[Abstract]
[Full Text]
-
Gupta, R. A., Brockman, J. A., Sarraf, P., Willson, T. M., DuBois, R. N.
(2001). Target Genes of Peroxisome Proliferator-activated Receptor gamma in Colorectal Cancer Cells. J. Biol. Chem.
276: 29681-29687
[Abstract]
[Full Text]
-
Cernuda-Morollon, E., Pineda-Molina, E., Canada, F. J., Perez-Sala, D.
(2001). 15-Deoxy-Delta 12,14-prostaglandin J2 Inhibition of NF-kappa B-DNA Binding through Covalent Modification of the p50 Subunit. J. Biol. Chem.
276: 35530-35536
[Abstract]
[Full Text]
-
Jones, D. C., Ding, X., Daynes, R. A.
(2002). Nuclear Receptor Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Is Expressed in Resting Murine Lymphocytes. THE PPARalpha IN T AND B LYMPHOCYTES IS BOTH TRANSACTIVATION AND TRANSREPRESSION COMPETENT. J. Biol. Chem.
277: 6838-6845
[Abstract]
[Full Text]
-
Schinner, S., Dellas, C., Schroder, M., Heinlein, C. A., Chang, C., Fischer, J., Knepel, W.
(2002). Repression of Glucagon Gene Transcription by Peroxisome Proliferator-activated Receptor gamma through Inhibition of Pax6 Transcriptional Activity. J. Biol. Chem.
277: 1941-1948
[Abstract]
[Full Text]